Artia Global Partners LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001937964

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 51 positions · Total reported value $495.64M · Top-10 concentration 62.7% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.3% · 13 new · 4 cut · 10 exited

Active Share (vs S&P 500): 98.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.6% · Prev Value $541.86M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.4% · Latest Value $495.64M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Artia Global Partners LP disclosed 51 equity positions with a combined reported value of $495.64M. The filing implies a focused portfolio: its ten largest positions account for 62.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were INSM ($67.23M), RVMD ($38.05M), ABVX ($36.07M). By sector, the heaviest allocations are Health Care 93.8%, Industrials 6.2%. Versus the prior quarter, allocation shifted toward Industrials (+4.2pp) and away from Health Care (-1.2pp), Other (-3.0pp).

Versus the prior quarter, Artia Global Partners LP opened 13 new positions, trimmed 4 and fully exited 10, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q3 2026 were RVTY ($12.38M), BRKR ($6.72M), TMO ($5.14M).

Of the 10 positions fully exited versus the prior quarter, the largest were XBI ($15.82M), IONS ($11.45M), ALMS ($7.84M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • RVTY REVVITY INC · $12.38M
  • BRKR BRUKER CORP · $6.72M
  • TMO THERMO FISHER SCIENTIFIC INC · $5.14M
  • TXG 10X GENOMICS INC · $4.18M
  • MRNA MODERNA INC · $3.85M
  • GRAL GRAIL INC · $3.53M
  • TWST TWIST BIOSCIENCE CORP · $2.96M
  • CORT CORCEPT THERAPEUTICS INC · $2.07M

Fully Exited (vs previous quarter)

  • XBI SPDR SERIES TRUST · prev qtr: $15.82M
  • IONS IONIS PHARMACEUTICALS INC · prev qtr: $11.45M
  • ALMS ALUMIS INC · prev qtr: $7.84M
  • SION SIONNA THERAPEUTICS INC · prev qtr: $5.27M
  • PALI PALISADE BIO INC · prev qtr: $4.16M
  • XENE XENON PHARMACEUTICALS INC · prev qtr: $3.92M
  • CMPX COMPASS THERAPEUTICS INC · prev qtr: $839.21K
  • KOD KODIAK SCIENCES INC · prev qtr: $663.06K

Insider Transactions (Form 4)

Latest Artia Global Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Artia Global Partners LP is an SEC-registered 13F filer based in Miami, FL, United States. As of Q3 2026 it reported 51 US equity positions with a combined value of $495.64M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: MIAMI, FL, United States
  • SEC registration: 801-125942 (status: Approved), registered 2022-06-23
  • Regulatory AUM (Form ADV): $778.89M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 51 positions · $495.64M reported value (Q3 2026)
  • Top 10 holdings = 62.7% of reported value
  • Largest position: INSM (INSMED INC) at 13.6%
  • Average position size: $9.72M

Sector Tilt

  • Health Care 93.8%
  • Industrials 6.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 13 new, 9 added, 4 reduced, 10 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund increased exposure to select biotech/healthcare names (e.g., GH, TVTX, BTSG) while trimming overweights (ABVX), suggesting a bullish but selective stance on healthcare innovation, possibly favoring clinical-stage biotechs with near-term catalysts. 2. Key moves: - Added: GH (+153.8% shares, +2.43% wt), TVTX (+17.5% shares, +1.17% wt), BTSG (+17.9% shares, +0.32% wt). - Reduced: ABVX (-29.5% shares, -5.42% wt). 3. Portfolio structure: Active, concentrated (51 positions), heavily tilted toward Health Care (100% of top 10), with moderate risk appetite (mix of large-caps like AZN and high-beta biotechs like TRVI). 4. Per-holding one-liner: - INSM: INSMED INC (CFR modulator for rare diseases) - RVMD: REVOLUTION MEDICINES INC (RAS pathway inhibitors) - ABVX: ABIVAX SA (immune-mediated diseases) - BTSG: BRIGHTSPRING (home healthcare services) - TRVI: TREVI THERAPEUTICS (urological disorders) - ARGX: ARGENX SE (immune-oncology) - TVTX: TRAVERE THERAPEUTICS (rare kidney diseases) - ALKS: ALKERMES PLC (CNS therapeutics) - GH: GUARDANT HEALTH INC (liquid biopsies) - AZN: ASTRAZENECA PLC (big pharma) 5. Style summary: Biotech-focused healthcare fund tactically scaling positions in high-growth clinical-stage names while trimming laggards.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 05:10

Sector Allocation

Health Care 93.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 589.05K $67.23M 13.56%
13.56%
Hold
2 185.39K $38.05M 7.68%
7.68%
Hold
3 364.27K $36.07M 7.28%
7.28%
Reduce
4 609.94K $34.61M 6.98%
6.98%
Add
5 2.21M $31.66M 6.39%
6.39%
Hold
6 29.74K $28.52M 5.75%
5.75%
Hold
7 398.49K $23.46M 4.73%
4.73%
Add
8 448.96K $18.19M 3.67%
3.67%
Hold
9 96.70K $17.25M 3.48%
3.48%
Add
10 98.38K $15.88M 3.21%
3.21%
Hold
11 65.12K $15.18M 3.06%
3.06%
Hold
12 165.74K $14.59M 2.94%
2.94%
Add
13 80.95K $12.38M 2.50%
2.50%
New
14 503.94K $12.26M 2.47%
2.47%
Hold
15 80.50K $11.70M 2.36%
2.36%
Add
16 27.10K $7.17M 1.45%
1.45%
Add
17 103.80K $6.72M 1.36%
1.36%
New
18 29.24K $6.60M 1.33%
1.33%
Add
19 161.18K $6.54M 1.32%
1.32%
Add
20 180.73K $5.89M 1.19%
1.19%
Hold
21 166.51K $5.59M 1.13%
1.13%
Add
22 7.61K $5.14M 1.04%
1.04%
New
23 464.44K $5.00M 1.01%
1.01%
Hold
24 129.80K $4.75M 0.96%
0.96%
Hold
25 70.70K $4.66M 0.94%
0.94%
Hold
26 96.28K $4.65M 0.94%
0.94%
Hold
27 24.99K $4.24M 0.86%
0.86%
Hold
28 46.30K $4.18M 0.84%
0.84%
New
29 17.74K $4.04M 0.81%
0.81%
Hold
30 50.52K $4.02M 0.81%
0.81%
Reduce
31 20.00K $3.85M 0.78%
0.78%
New
32 25.20K $3.53M 0.71%
0.71%
New
33 137.80K $3.46M 0.70%
0.70%
Hold
34 72.10K $3.31M 0.67%
0.67%
Hold
35 22.95K $3.23M 0.65%
0.65%
Hold
36 15.30K $2.96M 0.60%
0.60%
New
37 33.40K $2.78M 0.56%
0.56%
Hold
38 5.00K $2.71M 0.55%
0.55%
Hold
39 29.20K $2.18M 0.44%
0.44%
Hold
40 18.00K $2.07M 0.42%
0.42%
New
41 38.41K $1.91M 0.39%
0.39%
Hold
42 464.70K $1.52M 0.31%
0.31%
Reduce
43 334.40K $1.38M 0.28%
0.28%
New
44 5.80K $999.40K 0.20%
0.20%
New
45 553.74K $919.22K 0.18%
0.18%
Reduce
46 2.50K $728.08K 0.15%
0.15%
Hold
47 205.32K $496.88K 0.10%
0.10%
Hold
48 8.30K $486.55K 0.10%
0.10%
New
49 4.00K $356.12K 0.07%
0.07%
Hold
50 20.44K $262.30K 0.05%
0.05%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 90% R 90% F1 90% (modelled on 2026-Q2; 9/10 hit)

Low-confidence forecast This fund replaces about 34% of its Top-10 each quarter and backtests at F1 66% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 66% · recall 66% · F1 66% · avg rank error 3.2 · Top-10 turnover 34%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 90% 90% 90% NVO · MRK · LLY · ABBV · AZN · ARGX · VKTX · AXSM · NBIX · ITCI NVO · LLY · MRK · VKTX · ABBV · ITCI · ARGX · AZN · VRTX · AXSM
2024-Q2 80% 80% 80% NVO · LLY · MRK · VKTX · ABBV · ITCI · VRTX · ARGX · AZN · OCUL LLY · MRK · NVO · AZN · ITCI · VRTX · ALNY · VKTX · AXSM · ARGX
2024-Q3 80% 80% 80% LLY · MRK · NVO · ITCI · AZN · ALNY · VRTX · VKTX · AXSM · PCVX NVO · VKTX · ITCI · AZN · SLNO · LLY · ALNY · VRTX · PCVX · ARGX
2024-Q4 50% 50% 50% NVO · VKTX · ITCI · SLNO · AZN · LLY · ALNY · PCVX · VRTX · AXSM SLNO · MRUS · ITCI · ACLX · NUVL · PCVX · ALNY · AZN · RVMD · VRNA
2025-Q1 50% 50% 50% SLNO · MRUS · ITCI · NUVL · ACLX · PCVX · RVMD · ALNY · INSM · VRNA LLY · VRNA · ITCI · INSM · MRUS · PTGX · ACLX · AZN · BSX · DGX
2025-Q2 60% 60% 60% LLY · VRNA · ITCI · INSM · MRUS · PTGX · ACLX · AZN · BSX · DGX ARGX · SLNO · LLY · BSX · MRUS · DGX · AZN · VRNA · XBI · TRVI
2025-Q3 50% 50% 50% ARGX · SLNO · LLY · BSX · DGX · MRUS · AZN · VRNA · XBI · TRVI ARGX · INSM · SLNO · VRNA · QURE · MRUS · UGL · LLY · VRTX · ABVX
2025-Q4 50% 50% 50% ARGX · INSM · SLNO · VRNA · QURE · UGL · MRUS · VRTX · LLY · TRVI INSM · ARGX · LLY · VKTX · TRVI · QURE · NAMS · AZN · CDTX · EYPT
2026-Q1 60% 60% 60% INSM · LLY · ARGX · VKTX · QURE · TRVI · NAMS · AZN · EYPT · CDTX ABVX · INSM · LLY · TRVI · ARGX · AZN · NAMS · DNTH · RVMD · IONS
2026-Q2 70% 70% 70% ABVX · INSM · LLY · TRVI · ARGX · NAMS · AZN · DNTH · RVMD · IONS ABVX · INSM · TRVI · BTSG · RVMD · ARGX · ALKS · TVTX · AZN · NAMS
2026-Q3 ★ 90% 90% 90% ABVX · INSM · TRVI · BTSG · RVMD · ARGX · ALKS · TVTX · AZN · NAMS INSM · RVMD · ABVX · BTSG · TRVI · ARGX · TVTX · ALKS · GH · AZN

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings19 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-3.94%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+13.08%vs benchmark
Barra annualised vol32.4%Model estimate
Realised vol35.6%Annualised in window
Weighted beta0.76Raw exposure
Factor / specific risk53% / 47%Share of variance
Top-10 concentration88.1%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-16Artia Global Partners LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-3.94%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+13.08%Portfolio − benchmark
Arithmetic return sum-3.21%Difference vs compounded is the cross term
Weighted raw beta0.76Weighted holding betas
Realised volatility (annualised)35.61%Daily returns in window
Barra model volatility (annualised)32.40%Factor + specific
Factor share of variance52.8%Barra factors
Specific share of variance47.2%Stock residuals
Reported value$236.1M13F long US equity

2. Return attribution

The -3.21% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +3.02% 94.1%
Momentum & Growth 3 -4.51% -140.6%
Volatility & Tail Risk 7 +4.49% 139.7%
Industry 12 +6.69% 208.4%
Specific 1 -12.89% -401.6%
Return attribution (style + industry, %)-13.6-6.8+0.0+6.8+13.6Growth-0.24Amihud Illiquidity-0.39Max Drawdown+0.49Beta-0.50Non-linear Size+0.54Leverage (Downside Vol)+1.30Turnover+1.37Size+1.41Momentum-4.40Residual Volatility+4.70Skewness-5.58Health Care+6.68Historical Volatility-8.54Kurtosis+12.60
Factor Type Exposure Factor return Contribution Share of |return|
Kurtosis Style +1.68 +7.51% +12.60% 392.5%
Health Care Industry +0.96 +6.98% +6.68% 208.1%
Residual Volatility Style +1.43 +3.29% +4.70% 146.5%
Size Style -0.72 -1.95% +1.41% 43.8%
Turnover Style -0.29 -4.80% +1.37% 42.8%
Leverage (Downside Vol) Style -0.76 -1.71% +1.30% 40.6%
Non-linear Size Style +0.54 +1.01% +0.54% 16.8%
Max Drawdown Style -0.28 -1.76% +0.49% 15.3%
Short-term Reversal Style +0.15 +0.87% +0.13% 4.0%
Mid Cap Style -0.06 -1.94% +0.12% 3.6%
Growth Style -0.14 +1.75% -0.24% -7.6%
Amihud Illiquidity Style +0.89 -0.45% -0.39% -12.3%
Beta Style -0.11 +4.44% -0.50% -15.4%
Momentum Style +1.10 -4.00% -4.40% -137.0%
Skewness Style +1.27 -4.39% -5.58% -173.8%
Historical Volatility Style +0.61 -14.00% -8.54% -265.9%
Specific Specific — — -12.89% -401.6%

3. Risk attribution

Annualised volatility is 32.40%; factor risk explains 52.8% of variance and specific risk 47.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-51.0-25.5+0.0+25.5+51.0Non-linear Size-0.65Beta-0.47Industrials+0.54Skewness+1.02Max Drawdown+1.52Historical Volatility+1.57Residual Volatility+1.69Amihud Illiquidity+1.79Size+2.20Leverage (Downside Vol)+2.79Kurtosis+6.77Momentum+9.57Health Care+24.18Specific+47.19
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 47.2% +15.29% 15.3%
Health Care Industry +0.96 24.2% +7.84% 7.8%
Momentum Style +1.10 9.6% +3.10% 3.1%
Kurtosis Style +1.68 6.8% +2.19% 2.2%
Leverage (Downside Vol) Style -0.76 2.8% +0.90% 0.9%
Size Style -0.72 2.2% +0.71% 0.7%
Amihud Illiquidity Style +0.89 1.8% +0.58% 0.6%
Residual Volatility Style +1.43 1.7% +0.55% 0.6%
Historical Volatility Style +0.61 1.6% +0.51% 0.5%
Max Drawdown Style -0.28 1.5% +0.49% 0.5%
Skewness Style +1.27 1.0% +0.33% 0.3%
Industrials Industry +0.04 0.5% +0.18% 0.2%
Growth Style -0.14 0.3% +0.11% 0.1%
Short-term Reversal Style +0.15 -0.2% -0.07% -0.1%
Beta Style -0.11 -0.5% -0.15% -0.1%
Non-linear Size Style +0.54 -0.7% -0.21% -0.2%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.0-0.20.71.52.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.72 +2.10 -2.82
Non-linear Size +0.54 +1.68 -1.14
Mid Cap -0.06 +0.13 -0.19
Beta -0.11 +1.29 -1.41
Momentum +1.10 +0.72 +0.38
Short-term Reversal +0.15 -0.64 +0.79
Residual Volatility +1.43 -0.40 +1.83
Historical Volatility +0.61 +0.86 -0.25
Liquidity -0.06 +0.11 -0.18
Amihud Illiquidity +0.89 +1.16 -0.27
Turnover -0.29 +0.21 -0.49
Growth -0.14 +0.58 -0.72
Leverage (Downside Vol) -0.76 +0.14 -0.91
Skewness +1.27 +0.24 +1.03
Kurtosis +1.68 +0.21 +1.46
Max Drawdown -0.28 -0.08 -0.20

5. Industry allocation & Brinson

Industry allocation (weight, %)-9.619.147.876.5105.2Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 4.4% 11.1% -14.62% +4.36% -1.45% -2.11% +1.28% -1.12%
Health Care 95.6% 1.7% -3.62% +8.29% +23.87% -0.21% -11.18% -3.60%
Total +23.81% +14.01% -26.23% +11.60%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
INSM INSMED INC Health Care 28.47% +7.66% +2.18% Hold
RVMD REVOLUTION MEDICINES INC Health Care 16.11% -18.70% -3.01% Hold
ARGX ARGENX SE Health Care 12.08% -0.83% -0.10% Hold
GH GUARDANT HEALTH INC Health Care 7.30% -19.25% -1.41% Add
AZN ASTRAZENECA PLC Health Care 6.73% +13.96% +0.94% Hold
NAMS NEWAMSTERDAM PHARMA COMPANY Health Care 5.19% -19.98% -1.04% Hold
MRK MERCK & CO INC Health Care 4.95% -0.58% -0.03% Add
JNJ JOHNSON & JOHNSON Health Care 3.04% +6.73% +0.20% Add
TMO THERMO FISHER SCIENTIFIC INC Industrials 2.17% +2.41% +0.05% New
ROIV ROIVANT SCIENCES LTD Health Care 2.01% +5.58% +0.11% Hold
SRRK SCHOLAR ROCK HLDG CORP Health Care 1.97% -7.82% -0.15% Hold
TXG 10X GENOMICS INC Industrials 1.77% -39.14% -0.69% New
MRNA MODERNA INC Health Care 1.63% +11.79% +0.19% New
GRAL GRAIL INC Health Care 1.49% -24.64% -0.37% New
PTGX PROTAGONIST THERAPEUTICS INC Health Care 1.37% -11.40% -0.16% Hold
TWST TWIST BIOSCIENCE CORP Health Care 1.25% -45.64% -0.57% New
UTHR UNITED THERAPEUTICS CORP DEL Health Care 1.15% +8.49% +0.10% Hold
CORT CORCEPT THERAPEUTICS INC Health Care 0.88% -39.93% -0.35% New
A AGILENT TECHNOLOGIES INC Industrials 0.42% +0.50% +0.00% New
Contribution rank Symbol Sector Weight Return Contribution
1 INSM Health Care 28.47% +7.66% +2.18%
2 AZN Health Care 6.73% +13.96% +0.94%
3 JNJ Health Care 3.04% +6.73% +0.20%
4 MRNA Health Care 1.63% +11.79% +0.19%
5 ROIV Health Care 2.01% +5.58% +0.11%
6 UTHR Health Care 1.15% +8.49% +0.10%
7 TMO Industrials 2.17% +2.41% +0.05%
8 A Industrials 0.42% +0.50% +0.00%
9 TWST Health Care 1.25% -45.64% -0.57%
10 TXG Industrials 1.77% -39.14% -0.69%
11 NAMS Health Care 5.19% -19.98% -1.04%
12 GH Health Care 7.30% -19.25% -1.41%
13 RVMD Health Care 16.11% -18.70% -3.01%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -3.94%, versus -17.01% for the QQQ synthetic benchmark — an excess of +13.08%.
  2. Return attribution: the largest positive style/industry contributions came from Kurtosis +12.60%, Health Care +6.68%, Residual Volatility +4.70%; the largest drags came from Historical Volatility -8.54%, Skewness -5.58%, Momentum -4.40%. Specific (stock-level) return contributed -12.89%.
  3. Risk attribution: Barra model volatility is 32.40% annualised; factor risk explains 53% of variance and specific risk 47%. The largest factor risk sources are Health Care 24.2%, Momentum 9.6%, Kurtosis 6.8%.
  4. Style tilt: size -0.72, momentum +1.10, volatility +0.61, liquidity -0.06; the weighted raw beta is 0.76. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+93.9 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.81%, selection +14.01% and interaction -26.23%.
  6. Concentration: the top-10 positions are 88.1% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Artia Global Partners LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Artia Global Partners LP reported 51 equity positions worth $495.64M in aggregate; its largest disclosed positions were INSM ($67.23M), RVMD ($38.05M), ABVX ($36.07M).

How large is Artia Global Partners LP's portfolio?

Artia Global Partners LP reported $495.64M of long equity holdings across 51 positions as of 2026-Q3. Top-10 holdings account for 62.7% of reported value.

What is Artia Global Partners LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/artia-global-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →